Diabetic ketoacidosis in a case of pheochromocytoma

Diabetes Research and Clinical Practice

Volumn 54, Issue 2, 2001, Pages 137-142

  Ishii, C ^a   Inoue, K ^a   Negishi, K ^a   Tane, N ^a   Awata, T ^a   Katayama, S ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Diabetic ketoacidosis; Insulin resistance; Insulin secretion; Obesity; Pheochromocytoma

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CATECHOLAMINE; INSULIN;

ADRENAL TUMOR; ADULT; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CANCER SURGERY; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CAUCASIAN; CELL FUNCTION; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; FEMALE; HETEROZYGOSITY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; JAPAN; MEDICAL RECORD; OBESITY; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PHEOCHROMOCYTOMA; PREGNANCY DIABETES MELLITUS; PROTEIN DEFECT; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADULT; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; LEPTIN; PHEOCHROMOCYTOMA;

EID: 0034799040     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00261-3     Document Type: Article

References (25)

1. Pheochromocytoma with diabetes and hypertention
2. Bilateral pheochromocytoma associated with diabetes
3. Diabetes in association with other endocrine disorders symposium on diabetes
4. Diabetic ketoacidosis associated with pheochromocytoma
5. A case of diabetic ketoacidosis with pheochromocytoma
6. Diabetic ketoacidosis associated with pheochromocytoma of youth
7. Asymptomatic hyperglycaemia and early atherosclerotic changes
8. The triumvirate. β cells, muscle, liver. A collusion responsible for NIDDM
9. Epinephrine plasma metabolic clearance rate and physiological thresholds for metabolic and hemodynamic actions in man
10. A receptor mechanism for the inhibition of insulin release by epinephrine in man
11. The metabolic effects of epinephrine and related amines
12. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus
13. Carbohydrate and fat metabolism in patients with pheochromocytoma
14. Time of onset of NIDDM and β3-genetic variation in the β 3-adrenergic-receptor gene
15. Mutation of β 3-adrenergic receptor gene and response to treatment of obesity
16. Association of a polymorphism in the β 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns
17. Beta 3-adrenergic-receptor polymorphism: A genetic marker for visceral fat obesity and the insulin resistance syndrome
18. Tumor necrosis factor alpha: A key component of the obesity-diabetes link
19. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
20. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
21. Effects of leptin on insulin sensitivity in normal rats
22. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
23. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy
24. Effects of the obese gene product on body weight reduction in ob/ob mice